drugset
drugset / Trial / NCT01851954

Pharmacokinetic Study of Clarithromycin in Very Low Birth Weight (VLBW)

NCT01851954 ↗

Phase 2 Terminated 6 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to investigate the pharmacokinetics of clarithromycin which is used for premature infants with ureaplasma.

Timeline

Start
2013-02
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Clarithromycin Small molecule — Intravenous

Indications

Ureaplasma urethritis